Skip to content
TrialScanner

NCT04187560

Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults

Phase 1CompletedLBRXLead

Registry record

Lead sponsor
LB Pharmaceuticals Inc.
Conditions
Schizophrenia
Primary completion
Jul 1, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04187560 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04187560: Safety and Tolerability of... | TrialScanner